Trial0

Clinical trial · NCT07639645 · NOT_YET_RECRUITING · NA

Intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer

Sponsor: University of Valencia

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

The absence of social relationships negatively affects physical, psychological, and social health. In other words, it alters people's quality of life and makes active aging difficult. The investigators have designed a study to reduce unwanted loneliness and improve the living with process of family caregivers of people with Alzheimer disease through multiple interventions (music therapy, health education)

Interventions

  • Multimodal intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer · BEHAVIORAL

    The multimodal intervention will include these activities: 1. Health education workshops 2. Music therapy sessions 3. Physical exercise adapted to the physical conditions of each participant.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Family caregivers of people with Alzheimer's disease (AD).
* Primary family caregivers who live with the person with AD.
* The person with AD must be enrolled in one of the adult day care centers where the study is conducted.
* Ability to communicate in Spanish and/or Valencian.

Exclusion Criteria:

* Presence of moderate or severe cognitive impairment, mental disorder, significant sensory impairment, disabling chronic illness, or any medical condition that contraindicates participation in any of the study activities.
* Family caregivers of institutionalized individuals.
* Family caregivers of people with AD who have died.

Sites (1)

  • University of Valencia, Valencia, Valencia, Spain

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-06-15.